Publications by authors named "Yuki Oda"

Acute myeloid leukemia (AML) with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a dismal prognosis and poor response to conventional chemotherapy.

View Article and Find Full Text PDF

More than 13 years after the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident, concerns remain about drinking water contamination from artificial radionuclides and the ongoing discharge of tritiated water into the Pacific Ocean. However, natural radionuclides unrelated to FDNPP releases can also contribute to human radiation exposure. Here, we measured radionuclides in Fukushima tap and groundwater to assess exposure from Rn (natural); Cs (artificial); and H (both artificial and natural).

View Article and Find Full Text PDF

Introduction: Limited evidence exists regarding differences in post-operative renal function and ileal conduit-related complications, including ureteroenteric anastomotic stricture (UAS) and parastomal hernia (PH), between radical cystectomy (RC) with extracorporeal urinary diversion (ECUD) and robot-assisted RC with intracorporeal UD (ICUD).

Methods: We retrospectively collected the baseline and post-RC follow-up data from 179 patients receiving RC with ileal conduit UD (152 ECUD and 27 ICUD). The estimated glomerular filtration rate (eGFR, mL/min/1.

View Article and Find Full Text PDF

Aim: Down syndrome (DS) involves an extra chromosome 21 and tongue hypotonicity. This study examined reproducibility of tongue pressure measurement (TPM) in DS patients.

Methods: Thirty patients with DS (13 females) who were able to complete three measurements underwent a tongue pressure test (TPT).

View Article and Find Full Text PDF

[Patient] A 65-year-old man. [History of present illness] An abnormal chest shadow was noted in March of 2011, and hoarseness was observed in November of 2017. Both times, AL amyloidosis was diagnosed by biopsy.

View Article and Find Full Text PDF

Liver and spleen volume measurements are important for early detection and monitoring of liver disease. However, alterations in liver and spleen volumes with postural changes, i.e.

View Article and Find Full Text PDF

Surface collection efficiency (SCE) of a cellulose membrane filter (CMF) and a cellulose-glass fiber filter used in environmental monitoring for alpha-emitting radionuclides from nuclear facilities and natural radioactivity sources was evaluated for particles in the size range of 0.03-0.1 μm at different levels of face velocity.

View Article and Find Full Text PDF

Objectives: The objectives of the study are to evaluate the oncological and functional outcomes of three bladder preservation regimens: radiotherapy alone (RT-alone group), concurrent chemoradiotherapy (CRT) using gemcitabine plus platinum (GP-RT group), and low-dose gemcitabine (LD-Gem-RT group) for muscle-invasive bladder cancer.

Methods: The three oncological outcomes, bladder-intact distant metastasis-free survival (BI-DMFS), cancer-specific survival, and overall survival (OS), were compared among RT alone ( = 10), GP-RT ( = 16), and LD-Gem-RT ( = 11) groups. Treatment-related adverse events were evaluated against the Common Terminology Criteria for Adverse Events (version 5.

View Article and Find Full Text PDF
Article Synopsis
  • This study evaluated health-related quality of life (HRQoL) in 42 patients with advanced urothelial carcinoma (aUC) receiving various immune checkpoint inhibitors (ICIs), including pembrolizumab, avelumab, and nivolumab.
  • Results showed significant improvements in HRQoL for patients on pembrolizumab, while those on avelumab and nivolumab experienced mostly stable or deteriorated HRQoL, particularly in social and general health aspects.
  • The findings suggest that despite the challenges, many patients on ICI therapy maintained a stable HRQoL, aligning with previous clinical trial evidence.
View Article and Find Full Text PDF
Article Synopsis
  • The 15th Japan Bioanalysis Forum Symposium took place in Kyoto from February 5 to 7, 2024, focusing on the theme of science as a global effort.
  • The event covered various topics in analytical sciences, including ICH M10 guidelines, quantitative PCR, and the role of artificial intelligence, featuring insights from both domestic and international experts.
  • Around 360 participants from diverse sectors, like pharmaceuticals, research organizations, and regulatory bodies, attended the symposium either in-person or virtually.
View Article and Find Full Text PDF

Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a curative treatment option for multiple myeloma (MM), but few patients are eligible due to its high risk of treatment-related toxicity and relapse. Here, we report the feasibility and efficacy of allo-SCT after myeloablative conditioning with 8 Gy of total body irradiation (TBI) for reducing relapse of MM. We retrospectively analyzed data from 30 consecutive patients who received allo-SCT for MM after 8 Gy of TBI at Japanese Red Cross Medical Center between 2012 and 2021.

View Article and Find Full Text PDF

To retrospectively analyze whether the second revision of the international staging system (R2-ISS) influenced prognosis at treatment initiation in patients with multiple myeloma (MM) receiving anti-CD38 antibody-based triplet treatments. High-risk chromosomal abnormalities were examined from diagnosis to treatment initiation and considered positive if detected once. R2-ISS was recalculated at the initiation of treatment and defined as "dynamic R2-ISS.

View Article and Find Full Text PDF

Introduction: Duchenne muscular dystrophy (DMD) is a genetic disorder caused by mutations in the dystrophin-encoding gene that leads to muscle necrosis and degeneration with chronic inflammation during growth, resulting in progressive generalized weakness of the skeletal and cardiac muscles. We previously demonstrated the therapeutic effects of systemic administration of dental pulp mesenchymal stromal cells (DPSCs) in a DMD animal model. We showed preservation of long-term muscle function and slowing of disease progression.

View Article and Find Full Text PDF
Article Synopsis
  • Maintenance avelumab is recommended for patients with metastatic urothelial carcinoma (mUC) who have stable disease after first-line chemotherapy, while pembrolizumab offers an alternative option.
  • In a study of 626 patients, those transitioning from first-line chemotherapy to pembrolizumab had better outcomes in terms of response and progression-free survival compared to those moving to avelumab, especially if they had a partial response.
  • Overall survival rates were similar for both treatment options, highlighting that while pembrolizumab may provide better short-term efficacy, long-term survival outcomes remained unchanged.
View Article and Find Full Text PDF
Article Synopsis
  • Elotuzumab therapy in multiple myeloma (MM) patients may lead to cytomegalovirus reactivation (CMVRA), which had not been previously studied.
  • In a study involving 85 patients, 30 were tested for CMV, and 16 were positive, revealing a 6-month cumulative incidence rate of 18.4% for CMVRA.
  • Symptoms were noted in some patients, and the study highlights the need for close monitoring of CMVRA during elotuzumab treatment, particularly in those with a history of allogeneic stem cell transplantation.
View Article and Find Full Text PDF

The introduction of daratumumab has improved treatment outcomes for multiple myeloma (MM). However, infectious complications are a concern in patients receiving daratumumab. Although some reports have explored the association between daratumumab and cytomegalovirus (CMV) infection, most of these have focused on relapsed or refractory cases, and few describe patients with newly diagnosed MM (NDMM).

View Article and Find Full Text PDF

A time-course questionnaire survey using the chemotherapy-induced taste alteration scale (CiTAS) was conducted in patients with advanced urothelial carcinoma (UC) treated with systemic chemotherapy and/or immunotherapy. A total of 37 patients receiving systemic therapy with enfortumab vedotin (EV), platinum-based chemotherapy and immune checkpoint inhibitors were included in this study. No significant changes were observed in any of the CiTAS subscales during platinum-based chemotherapy and immune checkpoint inhibitor treatment, while EV therapy induced significant dysgeusia.

View Article and Find Full Text PDF

Complete metastasectomy (CM) in metastatic renal cell carcinoma (mRCC) has demonstrated efficacy in the cytokine era, but its effectiveness in the era of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) remains unclear. A multi-institutional database included clinicopathological data of 367 patients with mRCC. Patients were divided into two groups: the CM group and the non-CM group.

View Article and Find Full Text PDF
Article Synopsis
  • Elotuzumab is used for treating relapsed/refractory multiple myeloma, but the best patient selection and treatment sequence are not well defined.
  • A study analyzed 85 patients receiving elotuzumab, separating them into those with progressive disease (PD) and those without (non-PD), measuring their survival rates over a median follow-up of 33.6 months.
  • Results showed that patients without PD had significantly better progression-free survival (PFS) and overall survival (OS), especially those receiving elotuzumab post-hematopoietic stem cell transplantation, while those with triple-class refractory disease had worse outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • The IFM/DFCI group's study established that VRD induction followed by upfront autologous stem cell transplantation (ASCT) results in a median progression-free survival (PFS) of 50 months, setting ASCT as the standard treatment even with new therapies available.
  • A retrospective analysis of 124 patients treated at the Japanese Red Cross Medical Center found high response rates to VRD-based induction therapy, with 77% achieving a complete response (CR) and 94% reaching at least a very good partial response (VGPR).
  • Factors like age 65+, high-risk cytogenetics, and less than VGPR before ASCT were linked to poorer PFS, but achieving minimal residual disease (MRD)
View Article and Find Full Text PDF

A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_session0sqtpv11uds2s1c9g3rdkngt8fgu1rlk): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once